After a night’s sleep and a couple hundred angry comments and emails, I think I’ve figured a couple of things out about the Ryan Braun reaction and people’s overall feelings about MLB’s drug testing program. Mostly, though, I’m just dumbfounded at the cynicism and intellectual dishonesty of so many who wish to ignore the arbitrator’s ruling and cast Braun as a PED-using villain regardless.
For years, people argued for Major League Baseball to adopt a rigorous testing regime. Why? To end the speculation. To stop the “is he using or isn’t he” parlor games. Read every single column written about Jeff Bagwell’s Hall of Fame candidacy and you’ll find some variation of “but for so long there was no testing, so we just can’t know, and that uncertainty is horrible …” sentiment.
Now we have a testing program. And it’s amazing to me just how quickly the end product of that testing program — no suspension for Ryan Braun — is diminished or outright dismissed when results aren’t what people wanted.
I’m talking about those who don’t care that the procedures weren’t followed and say that they still don’t think Braun is clean, his name not cleared. Sure, you’re allowed to think that if you want, but just understand that if you do — if “we still don’t think he’s clean” or “questions still remain” holds — then there is no purpose whatsoever to have a testing program in the first place. Because even with one in place, people will just assume what they want to assume regardless of the end product, and that’s no different than where we were in 1998.
The reason? Because no scientific protocol has legitimacy if only some parts of it are adhered to and others aren’t. When you go with testing, you go with everything. You can’t say that the preliminary test results matter and the chain of custody protocols don’t. It’s all of a piece. It’s the entire process that lends drug testing its legitimacy, not just part of it.
But hey, if you still want to crap on Braun — if you still want to say “but his testosterone levels were high, so he’s suspect” or “MLB has egg on its face because the testing failed” — fine. Do so. It’s a free country. But if you do so, admit that you do it because you simply don’t like the results here. And spare me any whining about the past, and about how Major League Baseball was so lax in testing for so many years before now. Because as is evidenced by your Ryan Braun reactions, you wouldn’t have cared regardless.
Mike DiGiovanna of the Los Angeles Times reports that the Angels have agreed to terms on a minor league contract with right-handed reliever Javy Guerra. The deal includes an invitation to major league spring training.
Guerra was suspended 50 games by Major League Baseball last July after testing positive for a drug of abuse. That suspension is now over, though Guerra is probably ticketed for the Angels’ Triple-A affiliate to begin the 2016 season.
The 30-year-old made just three major league appearances in 2015 for the White Sox before getting outrighted off Chicago’s 40-man roster. He does own a 2.87 ERA in 150 1/3 career innings, but it has come with bouts of inconsistency and unreliability.
Maybe he can get everything going in the right direction with Anaheim.
As first reported by Bill Shanks of Fox Sports 1670, the Braves have signed right-handed reliever Carlos Torres to a minor league contract with an invitation to spring training.
Torres was waived by the Mets in January, somewhat surprisingly, and elected to become a free agent. The 33-year-old ultimately chose Atlanta, where he should have a good shot at an Opening Day roster out of spring training with the rapidly-rebuilding Braves.
Torres posted an ugly 4.68 ERA in 57 2/3 innings last season for the Mets, but he registered a gorgeous 3.06 ERA and 96 strikeouts across 97 innings in 2014.
If he gets off to a good start in 2016, he could become valuable trade bait.
Roberto Osuna became the youngest pitcher to ever play for the Blue Jays last season at age 20 and he rose to the challenge with a 2.58 ERA, 0.92 WHIP, and 75/16 K/BB ratio in 69 2/3 frames. Osuna eventually took over as Toronto’s closer, earning 20 regular-season saves and one in the American League Division Series — a five-out effort in Game 5 to close out the visiting Rangers.
But the Jays upgraded the back end of their bullpen this winter, acquiring Drew Storen from the Nationals in early January for speedy outfielder Ben Revere. Jesse Chavez was also brought to Toronto in a trade with the A’s.
Storen has more experience at closer than Osuna, and Storen struggled when the Nationals tried to put him in a setup role. Storen, in his final year of salary arbitration, also gets paid much more. He’s probably going to enter spring training as the favorite for the Jays’ ninth-inning gig, but there will be a competition …
Blue Jays general manager Ross Atkins told Ben Nicholson-Smith of Sportsnet.ca on Wednesday that he doesn’t expect the team to choose between Osuna or Storen until midway through spring training, if not later.
There’s been talk of making Osuna a starter, so add that wrinkle.
Storen, 28, boasts 95 career major league saves.
Baltimore’s front office appears to be lining up a run of potential roster additions leading into the beginning of spring training.
We’ve already passed along the reports suggesting they are close to a three-year deal with free agent starter Yovani Gallardo, but now FOX Sports’ Ken Rosenthal adds that free agent outfielder Dexter Fowler could be next on the Orioles’ target list. It they get those two deals done, the O’s could then chase free agent slugger Pedro Alvarez.
Rosenthal says the Orioles are even eyeing Jay Bruce of the Reds, though the FOX reporter hears the O’s might not have the prospects to pull off that kind of trade.
The focus for the Orioles out of the gate this winter was re-signing Matt Wieters and Chris Davis. Wieters accepted his one-year, $15.8 million qualifying offer in November and Davis was locked up to a seven-year, $161 million contract in mid-January.
Now the O’s are spending a little leftover cash on late-offseason additions to improve their position in what should be a tight 2016 American League East race.